Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Allergic Rhinitis and Conjunctivitis
•
Primary Care
How do you manage recurrent epistaxis from nasal steroids?
Related Questions
When do you consider lifelong AIT?
Do you routinely take a cancer history from patients being evaluated for atopy?
Do you retest for environmental aeroallergens when patients have relocated within the US between vastly different climates?
What are your recommendations for managing perivascular dermatitis with eosinophils unresponsive to high-dose antihistamines, a prednisone taper, and topical steroids?
Do you switch from 0.15 mg to 0.3 mg epinephrine at 55lbs or 66lbs?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
Do you recommend patients try antihistamines such as oral ketotifen that are not approved in the US but are approved in the EU for MCAS if currently available formulations have not been effective?
Have you observed adverse mental health side effects in patients who start montelukast?
What medications would you have a patient avoid with an IgE mediated reaction to cyclobenzaprine?
